Tandem Diabetes Care TNDM Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's accrued manufacturing costs?
- Tandem Diabetes Care (TNDM) reported accrued manufacturing costs of $55.7M in Q1 2026.
- How has Tandem Diabetes Care's accrued manufacturing costs changed year-over-year?
- Tandem Diabetes Care's accrued manufacturing costs increased by 10.4% year-over-year, from $50.45M to $55.7M.
- What is the long-term trend for Tandem Diabetes Care's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's accrued manufacturing costs has grown at a 15.6% compound annual growth rate (CAGR), from $34.16M to $70.41M.